Trial intelligence / Profile preview

Amlodipine and Losartan Combination for Stage 2 Hypertension

NCT01127217Phase 3Completed

Sponsor
Hanmi Pharmaceutical
Start
May 2009
Primary completion
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of losartan in hypertension (HTN), sponsored by Hanmi Pharmaceutical. Started May 2009; status: completed.

02

Drugs

losartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT01127217.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01127217.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call